BONE FINDINGS IN SYSTEMIC MASTOCYTOSIS

View at publisher Summarise with VIRAT
Authors: MEHTAP KILIÇ, Belgin Usta Güç
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Systemic mastocytosis (SM) is caused by the uncontrolled proliferation, activation and accumulation of mast cells (MCs) in multiple organs. Clinical manifestations result from MC degranulation with the release of MC derived mediators and/or MC infiltration can lead to symptoms ranging from mild to moderate severity. The skeleton is one of the primary target tissues in SM and skeletal involvement has been reported in approximately 50–70% of patients. Mast cells contribute to bone remodeling and may facilitate bone turnover, thereby having a key impact on bone metabolism. In SM osteopenia or osteoporosis, irrespective of the presence of fractures, constitutes the most common manifestation of skeletal involvement. Osteosclerosis or mixed-pattern skeletal involvement has likewise been report-ed less frequently. Therefore, skeletal assessment is crucial in patients with SM, and comprehensive clinical, biochemical, and imaging evaluations are recommended to assess bone health. As an initial treatment for osteoporosis in SM, antiresorptive therapies such as bisphosphonates or denosumab are appropriate; however, treatment should be individualized using a multidisciplinary and patient-cen-tered approach.

Fields of Study & Subjects

Mast cells and histamine Bone health and osteoporosis research Bone Metabolism and Diseases

Publication details

Journal / source
Turkiye Klinikleri eBooks
Pages
185–199
Publication date
1 January 2026
Language
EN
Document type
Book chapter